Tech that detects risk of metabolic disorders in non-invasive way bags Anjani Mashelkar Prize

Did you ever imagine that just by scanning your fingertips, you could uncover crucial insights about your metabolic health and predict the risk of conditions such as diabetes, hypertension and high cholesterol?

The 13th Anjani Mashelkar Prize awardee has brought this imagination to reality through its Intelligent Health Risk Assessment (IHRA), a first-of-its-kind ultra- affordable early screening solution for detection of Type 2 Diabetes, hypertension and cholesterol using completely non-invasive technology, and that too for less than Rs 10 per scan.

Metabolic comorbidities are emerging as a global pandemic, affecting over 460 million adults worldwide, with a staggering 50% of these cases undiagnosed. Gayathri Choda, founder and CEO of Aarca Research Pvt. Ltd., along with her team, offers a disruptive, pain-free and cost-effective solution, providing a real-time metabolic health panel including 18 parameters just by inserting fingers into a socket of sensors.